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our goal was to examine the association between physical multimorbidity and subjective cognitive 
complaints (SCC) using UK nationally representative cross-sectional community-based data, and to 
quantify the extent to which a broad range of mainly psychological and behavioral factors explain 
this relationship. Data from the 2007 Adult Psychiatric Morbidity Survey were analyzed [N = 7399 
adults, mean (SD) age 46.3 (18.6) years, 48.6% men]. Multimorbidity was defined as ≥2 physical 
diseases. SCC included two different cognitive constructs: subjective concentration and memory 
complaints. Multivariable logistic regression and mediation analyses were conducted. Multimorbidity 
was associated with higher prevalence of subjective concentration (30.7% vs. 17.3%) and memory 
complaints (42.8% vs. 22.9%) compared to no multimorbidity. In the regression model adjusted for 
sociodemographics, multimorbidity was associated with subjective concentration (OR = 2.58; 95% 
ci = 2.25–2.96) and memory complaints (OR = 2.34; 95% CI = 2.08–2.62). Sleep problems, stressful life 
events and any anxiety disorder explained 21–23%, 20–22% and 14–15% of the multimorbidity-SCC 
association, respectively. Multimorbidity and SCC are highly co-morbid. The utility of SCC screening in 
identifying individuals at high risk for future cognitive decline among individuals with multimorbidity 
should be assessed.
Cognition is commonly defined as the ability to process information from the environment and the internal rep-
resentation of this information via multiple mechanisms1. Cognition includes different cognitive processes such 
as attention, concentration, memory, reasoning, and decision-making. Subjective cognitive complaints (SCC) 
are everyday memory and related cognitive concerns expressed by people with or without objective evidence of 
cognitive impairment and are common in all age groups2. A nationally representative study of adults from the UK 
showed that almost one third of the population reported forgetfulness in the last month, and that more than 6% 
had forgotten something important in the last week3. It was further observed in another study conducted in the 
same country that the prevalence of subjective concentration complaints was between 7% and 10% in the general 
population4. Although there is controversy regarding the degree to which SCC and objective measures of cogni-
tion (e.g., assessed using standardized neuropsychological testing) correlate2, it is recognized that identifying SCC 
can provide a meaningful indicator of a person’s current cognitive functioning and may identify people at pro-
nounced risk of future cognitive decline, even in the presence of normal baseline objective cognition2. Biological 
changes such as increases in white matter lesions, temporal atrophy, and altered cerebrospinal fluid biomarkers 
have also been observed in individuals with SCC5–7.
In recent years, there has been a growing interest in the relationship between multimorbidity and subjec-
tive cognitive function8–10. Multimorbidity, which is often defined as ≥2 chronic diseases in a single individ-
ual, is increasingly common, and has a significant impact on disability, quality of life, polypharmacy, premature 
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mortality and health care costs11. Given that SCC is also known to substantially undermine quality of life12, and 
to be positively associated with mental disorders13 and all-cause mortality14, it is of vital importance to under-
stand the co-occurrence of SCC and multimorbidity. Furthermore, several longitudinal studies have found that 
multimorbidity may precede cognitive decline as assessed by objective measures, and it has been suggested that 
it may be a risk factor for cognitive impairment and possibly dementia15. It has been hypothesized that chronic 
physical conditions may lead to cognitive decline via atherosclerosis, microvascular changes, and inflammatory 
processes16, and these factors may cumulatively amplify the risk for cognitive decline especially in individuals 
with multimorbidity. However, there is limited evidence on the association between multimorbidity and SCC. 
This is an important omission because SCC can be a marker of cognitive decline even in the presence of normal 
objective cognition, while it can serve as a rapid clinical assessment of cognitive function as it does not require 
burdensome neuropsychological testing2.
The first study on multimorbidity and SCC was conducted in 2011 and included more than 15000 persons aged 
55 years and over from the Netherlands8. This study found a positive association between multimorbidity and SCC, 
and this association was modified by age, with the relationship between multimorbidity and SCC being stronger in 
people aged 55–69 years than in those aged 70 years and over. These findings were later corroborated in two other 
population-based studies from Sweden and Spain9,10. In the study conducted in Spain (N = 1342 elderly people), the 
prevalence of subjective memory complaints increased from 20.8% in participants without any medical condition 
to 34.1% in those with four or more medical conditions10. The main limitations of these three studies are that they 
included older adults only, despite the fact that SCC is also known to be frequent in younger ages17 and that the 
prevalence of multimorbidity is not negligible even in younger adults18. For example, a large community-based study 
showed that almost 30% of people aged 25–35 years considered themselves as being forgetful17, while the prevalence 
of multimorbidity in people aged 25–44 years has been reported to be 9.3%18. Furthermore, previous research inves-
tigating the association between cognitive complaints and single physical diseases among young adults used clinical 
samples (e.g., patients with epilepsy, cancer, schizophrenia) and there are no studies on this association in young 
people using community-based samples3,4. Another important limitation is that none of these studies were nationally 
representative. This severely limits the generalizability of the previous studies focusing on the multimorbidity-SCC 
relationship. Furthermore, to the best of our knowledge, there are no studies that aimed to identify potential influ-
ential factors in the association between multimorbidity and SCC. Several variables such as obesity19,20, smoking21,22, 
alcohol use23,24, stress and stressful life events25–27, depression28,29, anxiety13,30 or sleep problems31,32 are known to be 
associated with both multimorbidity and cognitive impairment, and might a play major role in this relationship.
Therefore, the goal of the present study using nationally representative, community-based data from the UK was to 
examine the association between multimorbidity and SCC, and to quantify the extent to which a broad range of mainly 
psychological and behavioral factors explain this relationship. Given the high prevalence of SCC in the UK3, and the 
upward trend in multimorbidity mainly associated with increased life expectancy in this setting33, a deeper understand-
ing of the multimorbidity-SCC association may provide important information for the prevention and management of 
cognitive decline and possibly dementia. In particular, since the pathophysiological processes of dementia may begin 
many years prior to diagnosis34, there is the need to focus not only on older populations, but younger populations.
Results
Sample characteristics. This nationally representative study included 7399 participants aged ≥16 
years without a doctor’s diagnosis of dementia or Alzheimer’s disease. The mean (SD) age of the population 
was 46.3 (18.6) years and 48.6% were men. The prevalence (95% CI) of multimorbidity, subjective concentra-
tion complaints and subjective memory complaints were 35.1% (33.9–36.4%), 22.0% (20.9–23.2%) and 29.9% 
(28.7–31.1%), respectively. The sample characteristics are reported in Table 1. Compared to people without mul-
timorbidity, people with this condition were significantly more likely to be women, older and British White, while 
they also had higher mean number of stressful life events, and higher prevalence of no qualification, low income, 
obesity, smoking, depression, any anxiety disorder and sleep problems.
prevalence of Scc by number of chronic conditions. The prevalence of SCC increased with increasing 
number of chronic conditions with the prevalence ranging from 15.4% in individuals with no chronic conditions 
to 40.6% in those with ≥4 chronic conditions for subjective concentration complaints and from 19.1% to 57.6% 
for subjective memory complaints (Fig. 1).
prevalence of Scc by presence of physical disease and multimorbidity. The presence of SCC was 
positively and significantly associated with each of the 20 physical diseases except cancer, diabetes and stroke for 
subjective concentration complaints and only stroke for subjective memory complaints (Table 2). The OR was 
particularly large (i.e., OR > 3) for epilepsy/fits and liver problems for subjective concentration complaints, while 
this was the case for bladder problems/incontinence and epilepsy/fits in terms of subjective memory complaints. 
Multimorbidity was associated with higher prevalence of subjective concentration (30.7% vs. 17.3%) and mem-
ory complaints (42.8% vs. 22.9%) compared to no multimorbidity. The results of the tetrachoric correlation for 
individual physical diseases by age group are displayed in Appendix 1. There was a stronger tendency for hyper-
tension and diabetes to co-occur or for allergy to co-exist with asthma among the younger age groups. There were 
fewer distinct patterns in the oldest age group with the strongest correlation being observed between asthma and 
bronchitis or cataract and epilepsy.
Association between multimorbidity and Scc estimated by multivariable logistic regression 
analyses. After adjustment for sociodemographic factors, physical multimorbidity was associated with higher 
odds for both subjective concentration (OR = 2.58; 95% CI = 2.25–2.96) and memory complaints (OR = 2.34; 
95% CI = 2.08–2.62) in the total sample (Table 3). Similar associations were found in the different age groups 
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with ORs ranging from 2.48 to 2.77 for subjective concentration complaints and from 2.12 to 2.40 for subjective 
memory complaints.
Mediation analysis. Table 4 shows the extent to which the association between multimorbidity and 





Male 48.6 51.6 42.9
<0.001
Female 51.4 48.4 57.1
Age (years)
16–44 50.0 61.4 29.1
<0.00145–64 31.0 26.9 38.5
≥65 19.0 11.7 32.4
British White
No 14.9 17.0 10.9
<0.001
Yes 85.1 83.0 89.1
Qualification
No 23.9 19.7 31.8
<0.001
Yes 76.1 80.3 68.2
Income
High 35.8 39.2 29.8
<0.001Middle 32.6 32.0 33.8
Low 31.6 28.8 36.4
Obesity
No 82.3 86.3 75.1
<0.001
Yes 17.7 13.7 24.9
Smoking status
Never 34.8 36.7 31.4
<0.001
Quit/Current 65.2 63.3 68.6
Alcohol dependence
No 92.3 91.5 93.8
0.002
Yes 7.7 8.5 6.2
Perceived stress
No 39.4 39.0 40.1
0.398
Yes 60.6 61.0 59.9
Number of stressful life events Mean (SD) 3.4 (2.4) 3.0 (2.2) 4.2 (2.7) <0.001
Depression
No 97.0 98.0 95.1
<0.001
Yes 3.0 2.0 4.9
Any anxiety disorder
No 93.3 95.3 89.4
<0.001
Yes 6.7 4.7 10.6
Sleep problems
No 57.6 63.9 46.0
<0.001
Yes 42.4 36.1 54.0
Table 1. Characteristics of individuals included in this study (overall and by physical multimorbidity status). 
Physical multimorbidity was defined as ≥2 physical conditions. aP-values were based on Chi-squared tests 
except for the number of stressful life events (t-test).
Figure 1. Prevalence of subjective concentration and memory complaints by number of chronic physical 
conditions. Subjective concentration complaints were assessed with the following question: “In the past month, 
have you had any problems with concentrating on what you were doing?”. Subjective memory complaints were 
assessed with the following question: “Have you noticed any problems with forgetting things in the past month?”.
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multimorbidity-SCC association, with the mediated percentage being 22.8% for subjective concentration com-
plaints and 20.6% for subjective memory complaints. The two other major influential factors were stressful 
life events (concentration: 22.1%; memory: 20.1%) and any anxiety disorder (14.9% and 14.4%, respectively). 
Collectively, the eight influential factors explained 47.5% and 43.3% of the relationship of multimorbidity with 
subjective concentration and memory complaints, respectively.
Discussion
We found in this large nationally representative study including individuals aged ≥ 16 years from the UK that the 
prevalence of SCC increased with the number of chronic conditions. Most individual physical diseases were pos-
itively associated with SCC. In addition, multimorbidity was independently associated with a 2.58- and 2.34-fold 
increase in the odds for subjective concentration and memory complaints, respectively. The association was sim-
ilar between different age groups despite the fact that the underlying multimorbidity pattern may differ by age 
Physical disease Category
Subjective concentration 
complaints P-valuea OR (95% CI)
Subjective memory 
complaints P-valuea OR (95% CI)
Allergy
No 21.2
<0.001 1.61 [1.29, 2.03]
29.1




<0.001 1.54 [1.32, 1.81]
27.9




<0.001 1.72 [1.41, 2.09]
29.0




<0.001 2.38 [1.85, 3.05]
29.0
<0.001 3.20 [2.51, 4.10]
Yes 39.3 56.7
Bone, back, joint or muscle 
problems
No 19.2
<0.001 1.97 [1.73, 2.24]
26.1




<0.001 1.75 [1.37, 2.24]
29.2




0.002 1.61 [1.19, 2.19]
29.4




0.611 1.12 [0.72, 1.76]
29.7




<0.001 1.29 [1.11, 1.49]
28.4




0.086 1.26 [0.97, 1.63]
29.4




0.007 1.32 [1.08, 1.61]
28.8




<0.001 3.43 [1.78, 6.61]
29.8




<0.001 1.79 [1.31, 2.45]
29.4




0.046 1.16 [1.00, 1.35]
28.3




0.033 2.14 [1.05, 4.39]
29.8




<0.001 3.61 [2.15, 6.06]
29.7
0.001 2.37 [1.40, 4.01]
Yes 50.1 50.1
Migraine or frequent headaches
No 20.4
<0.001 2.66 [2.19, 3.24]
28.1




<0.001 1.80 [1.50, 2.16]
28.7
<0.001 1.68 [1.40, 2.00]
Yes 32.2 40.3
Stomach ulcer or other digestive 
problems
No 21.2
<0.001 2.07 [1.66, 2.57]
28.8




0.998 1.00 [0.46, 2.18]
29.8
0.110 1.70 [0.88, 3.27]
Yes 22.0 41.9
Table 2. Prevalence of subjective concentration and memory complaints by physical disease. Abbreviations: 
OR Odds ratio; CI Confidence interval. Subjective concentration complaints were assessed with the following 
question: “In the past month, have you had any problems with concentrating on what you were doing?”. 
Subjective memory complaints were assessed with the following question: “Have you noticed any problems with 
forgetting things in the past month?”. aP-values were based on Chi-squared tests.
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groups. Finally, sleep problems, stressful life events and any anxiety disorder individually explained approxi-
mately 14–23% of the multimorbidity-SCC relationship.
Most of the individual chronic conditions were positively associated with subjective concentration and mem-
ory complaints. In the past years, there has been an important literature about the potential impact of these indi-
vidual chronic conditions on the risks for SCC. In a cross-sectional epidemiological study, impaired vision and 
hearing were found to be significant predictors of SCC10. The authors hypothesized that, as vision and hearing are 
tightly related to cognitive functions, severe impairment of these senses might favor the development of memory 
problems. Another study including 188 patients diagnosed with migraine reported a rate of subjective cognitive 
decline of 44.7% in the sample, and showed that both depression and short sleep duration during weekdays were 
risk factors for subjective cognitive decline35. More recently, a study including 670 adults attending an epilepsy 
clinic showed that more than 40% of the patients reported subjective cognitive impairment, and that subjective 
cognitive impairment was strongly impacted by depression, the number of antiepileptic medications and seizure 
frequency36.
Given the previously reported association between the individual chronic conditions and SCC, it is reason-
able to assume that individuals with greater numbers of chronic conditions (i.e., multimorbidity) would be at 
particularly high risk for SCC. However, apart from the contribution of individual physical contributions to 
this association, it is also possible that multimorbidity per se may be an independent risk factor for SCC. First, 
multimorbidity is positively associated with frailty37, while frailty is related to subjective cognitive decline in 
older adults without dementia38. Second, some chronic conditions (e.g., heart disease, cerebrovascular disease) 
may synergistically accelerate cognitive decline15. Third, people with multimorbidity are at an increased risk for 
polypharmacy39, and polypharmacy is a predictor of poorer cognitive capability40.
In our study, multimorbidity was associated with higher odds for SCC, and 21–23%, 20–22%, and 14–15% 
of this association was individually explained by sleep problems, stressful life events and anxiety, respectively. 
One population-based study including 42116 adults aged ≥50 years from nine countries found that many of 
the chronic conditions assessed in our study were associated with sleep problems31, and that there was a linear 
dose-dependent association between the number of chronic conditions and sleep problems. Symptoms of the 
chronic conditions (e.g., nocturnal symptoms in asthma or nocturia in diabetes) and the potential co-existence 
of sleep-disordered breathing with some chronic conditions (e.g., chronic lung disease, diabetes) might explain 
the heightened risk for sleep problems in people with chronic conditions31. A positive relationship between sleep 
problems and objective and subjective cognitive function has further been reported32,41. The higher likelihood of 
use of hypnotics and anxiolytics among people with multimorbidity may partly explain our findings. It has been 
reported that multimorbidity is associated with a 15-fold increase in the odds of receiving hypnotic or anxiolytic 
drugs42, while the negative impact of these medications on cognition is well-known43. Finally, it is also possible 
that self-perception of cognitive abilities is better in “good sleepers” than in “bad sleepers”32,44.
Stressful life events and any anxiety disorder were additional influential factors in the relationship between 
multimorbidity and SCC. A positive association between childhood adversities and multimorbidity in adulthood 
has been reported26, while another study of earthquake survivors showed prospectively that stressful life events 
were important determinants of future multimorbidity onset45. These findings suggest that stressful life events 
may be a cause rather than a consequence of multimorbidity, and they underline the fact that multimorbidity may 
be a complex psychosocial concept. Stressful life events have also been shown to increase the risk for self-reported 
memory problems25. The impact of stressful life events on both multimorbidity and SCC might be mediated by 
dysregulations in the hypothalamic-pituitary-adrenal (HPA) axis27,46,47.
Regarding anxiety disorders, elevated anxiety has been reported to be more frequent in individuals with mul-
timorbidity than in those without multimorbidity30. Anxiety levels may be elevated in individuals with multi-
morbidity because of worries of having an illness and difficulties adjusting to the burden of multimorbidity48. 
An analysis of community-dwelling elderly persons with normal physical examination further revealed that sub-
jective memory complaints were associated with anxiety13. Previous studies have also shown that SCC may be 
a reflection of health anxiety3, while studies using objective measures of cognitive function showed that anxiety 
leads to greater cognitive decline, and that this may be due to interferences with cognitive performance and 
excessively high concentrations of circulating catecholamines and glucocorticoids49,50. Interestingly, in our study, 
depression was not a mediator in the association between multimorbidity and SCC. This was an unexpected find-
ing given the previous reports that depression is highly prevalent in individuals with somatic disorders51 and that 
Overall Aged 16–44 years Aged 45–64 years Aged ≥65 years
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
SCC 2.58 [2.25, 2.96] 2.48 [2.02, 3.06] 2.77 [2.20, 3.50] 2.57 [1.90, 3.47]
SMC 2.34 [2.08, 2.62] 2.40 [1.91, 3.00] 2.39 [1.97, 2.89] 2.12 [1.67, 2.68]
Table 3. The association of physical multimorbidity (independent variable) with subjective concentration 
and memory complaints (dependent variables) estimated by multivariable logistic regression. Abbreviations: 
OR Odds ratio; CI Confidence interval; SCC Subjective concentration complaints; SMC Subjective memory 
complaints. Physical multimorbidity was defined as ≥2 physical conditions. Subjective concentration 
complaints were assessed with the following question: “In the past month, have you had any problems with 
concentrating on what you were doing?”. Subjective memory complaints were assessed with the following 
question: “Have you noticed any problems with forgetting things in the past month?”. Models were adjusted for 
sex, age, ethnicity, qualification and income. All p-values were lower than 0.001.
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depression and cognitive impairment are highly comorbid52. The reason for this is unclear and future studies are 
warranted to assess whether our results can be corroborated.
Finally, the fact that SCC was significantly associated with multimorbidity even after adjustment for all the 
potential influential factors (i.e., significant direct effect) suggests that there are other factors which may explain 
the multimorbidity-SCC association. These factors might include inflammation, dysregulation of the HPA axis, 
fatigue, polypharmacy (≥5 drugs taken at the same time) and drugs interactions9,11.
Interestingly, we also found that the strength of the multimorbidity-SCC association was similar between the 
different age groups (16–44, 45–64 and ≥65 years), suggesting that it may be important to focus on multimor-
bidity throughout the life course as a potential risk factor for SCC and possibly future cognitive decline. This 
finding is of particular interest because our tetrachoric analysis highlighted important differences in terms of 
correlations between individual physical diseases by age group, and because previous research has shown that 
multimorbidity patterns vary with age53, suggesting that the effects of multimorbidity on SCC likely involve a 
wide range of chronic conditions. However, since contradictory results have been obtained in the past, these 
results must be interpreted with caution. In fact, one study found that there was a significant two-way interaction 
between physical multimorbidity and age, and that the relationship of multimorbidity with SCC was stronger in 
participants aged 55–69 years than in those aged ≥70 years8. The authors suggested that, this may be due to the 
fact that younger individuals are professionally active in life, and that they might experience problems related to 
their forgetfulness more frequently than older individuals.
Based on the present findings, clinicians should be aware that subjective concentration and memory com-
plaints are highly prevalent in individuals with multimorbidity. Screening for SCC among people with multimor-
bidity may be important at all ages for the prevention of more severe cognitive disorders in this population. In 
particular, there is burgeoning evidence that intervening in mid-life is crucial54, although how cognitive function 
(especially SCC) among younger adults predicts future cognitive decline is currently largely unknown and should 
be assessed in future studies. The subjective nature of SCC makes it a much more likely candidate for rapid clinical 
assessment for cognitive function in individuals with multimorbidity given that SCC can be self-reported and 
does not require burdensome neuropsychological testing and specially trained staff. Based on our study results, 
it is possible that sleep problems, stressful life events and anxiety may be underlying factors which contribute 
to a higher odds for SSC in individuals with multimorbidity. When an individual with multimorbidity is found 
to have SCC, the clinician can screen for and potentially manage these conditions to improve SCC not only to 
reduce the risk for future cognitive decline but also to improve clinical outcome and the quality of life of the 
patient. Finally, in terms of future research, longitudinal studies are warranted to provide further insight into the 
potentially complex interplay of factors that link multimorbidity and SCC, while based on our findings, we call 
Total effect Direct effect Indirect effect
OR [95% CI] P-value OR [95% CI] P-value OR [95% CI] P-value %Mediateda
Subjective concentration complaints
Obesity 2.58 [2.25, 2.96] <0.001 2.57 [2.24, 2.95] <0.001 1.00 [0.99, 1.02] 0.708 NA
Smoking 2.58 [2.26, 2.95] <0.001 2.56 [2.24, 2.93] <0.001 1.01 [1.00, 1.02] 0.047 0.8
Alcohol dependence 2.60 [2.27, 2.97] <0.001 2.57 [2.25, 2.94] <0.001 1.01 [1.00, 1.02] 0.130 NA
Number of stressful life events 2.60 [2.26, 2.98] <0.001 2.10 [1.83, 2.41] <0.001 1.23 [1.19, 1.29] <0.001 22.1
Perceived stress 2.67 [2.32, 3.06] <0.001 2.45 [2.13, 2.81] <0.001 1.09 [1.06, 1.12] <0.001 8.8
Depression 2.67 [2.32, 3.07] <0.001 2.44 [2.13, 2.81] <0.001 1.09 [1.06, 1.12] <0.001 8.9
Any anxiety disorder 2.64 [2.30, 3.03] <0.001 2.29 [1.99, 2.62] <0.001 1.16 [1.12, 1.20] <0.001 14.9
Sleep problems 2.74 [2.39, 3.15] <0.001 2.18 [1.90, 2.50] <0.001 1.26 [1.21, 1.31] <0.001 22.8
Total 2.88 [2.47, 3.36] <0.001 1.74 [1.50, 2.03] <0.001 1.65 [1.54, 1.78] <0.001 47.5
Subjective memory complaints
Obesity 2.39 [2.13, 2.69] <0.001 2.37 [2.11, 2.67] <0.001 1.01 [0.99, 1.02] 0.302 NA
Smoking 2.34 [2.09, 2.63] <0.001 2.31 [2.06, 2.60] <0.001 1.01 [1.00, 1.02] 0.010 1.5
Alcohol dependence 2.35 [2.09, 2.64] <0.001 2.33 [2.07, 2.62] <0.001 1.01 [1.00, 1.02] 0.133 NA
Number of stressful life events 2.37 [2.11, 2.67] <0.001 1.99 [1.77, 2.25] <0.001 1.19 [1.15, 1.23] <0.001 20.1
Perceived stress 2.38 [2.11, 2.68] <0.001 2.23 [1.98, 2.51] <0.001 1.07 [1.05, 1.09] <0.001 7.6
Depression 2.41 [2.14, 2.71] <0.001 2.23 [1.98, 2.51] <0.001 1.08 [1.05, 1.11] <0.001 8.7
Any anxiety disorder 2.41 [2.14, 2.71] <0.001 2.12 [1.88, 2.39] <0.001 1.13 [1.10, 1.17] <0.001 14.4
Sleep problems 2.44 [2.16, 2.76] <0.001 2.03 [1.80, 2.29] <0.001 1.20 [1.16, 1.25] <0.001 20.6
Total 2.65 [2.33, 3.02] <0.002 1.74 [1.53, 1.98] <0.001 1.53 [1.43, 1.63] <0.001 43.3
Table 4. Contribution of potential influential factors in the association of physical multimorbidity with 
subjective concentration and memory complaints. Abbreviations: OR Odds ratio; CI Confidence interval. 
Physical multimorbidity was defined as ≥2 physical conditions. Subjective concentration complaints were 
assessed with the following question: “In the past month, have you had any problems with concentrating on 
what you were doing?”. Subjective memory complaints were assessed with the following question: “Have you 
noticed any problems with forgetting things in the past month?”. Model was adjusted for sex, age, ethnicity, 
qualification and income. aMediated percentage was only calculated when the indirect effect was significant 
(P < 0.05).
7Scientific RepoRtS |         (2019) 9:12417  | https://doi.org/10.1038/s41598-019-48894-8
www.nature.com/scientificreportswww.nature.com/scientificreports/
for future work on the age difference in the multimorbidity-SCC association, the role of depression in this asso-
ciation, and the potential utility of screening for SCC in individuals with physical diseases or multimorbidity to 
identify individuals at high risk for future cognitive decline and possibly dementia.
The strengths of the study include the large sample size, the use of nationally representative data, and the anal-
ysis which allowed for quantification of the extent to which various factors might explain the multimorbidity-SCC 
relationship. However, the study results should be interpreted in the light of several limitations. First, although we 
included 20 common physical diseases in our study, this is by no means an exhaustive list of all physical conditions. 
Thus, the results may have differed if more diseases were included. Second, subjective concentration and memory 
complaints were assessed with a single question. Thus, it is possible that the association between multimorbidity 
and SCC observed in our study may have differed with the use of a more complete measure. However, there are no 
standardized measures to capture SCC, and the use of a single question to assess SCC is common4. Furthermore, 
the prevalence of SCC in our study was within previously reported ranges3,55,56. Third, although the accuracy of 
patients’ self-reports of diagnoses has been previously reported to be satisfactory57,58, the use of self-reported data 
may have biased our findings. Fourth, individuals who were considered to have a level of cognitive impairment 
severe enough to preclude the possibility to participate in the survey, and those with a self-reported diagnosis of 
dementia or Alzheimer’s disease were excluded from the analysis. However, owing to the fact that the study was not 
designed to make clinical diagnoses of dementia, it is possible that the sample does not consist solely of cognitively 
healthy individuals. Fifth, because the survey did not include the institutionalized and the homeless, our study 
findings cannot be generalized to these populations, where multimorbidity and SCC may be particularly prevalent. 
Sixth, the survey response rate was 57% and this may have impacted the present findings. That being said, this rate is 
similar to previous national surveys59. Furthermore, non-responders were likely to have had similar characteristics 
to responders, as there were only minor differences in the results when using and not using non-response weights, 
which corrected for a range of sociodemographic and area characteristics. Finally, the design of the present study 
was cross-sectional, and it was thus not possible to determine causality or temporality in the multimorbidity-SCC 
relationship. Relatedly, mediation and confounding are identical statistically and can be distinguished only on con-
ceptual grounds60. While many of the influential factors assessed in this study can be conceptualized as mediators, 
it is not possible to determine whether the attenuation in the ORs after the inclusion of the influential factor is due 
to mediation or confounding in our cross-sectional study. Nonetheless, given that the influential factors in the 
association between multimorbidity and SCC are largely unknown, we believe that our study provides an important 
platform for future longitudinal studies to provide more concrete evidence for the establishment of causality.
In conclusion, the prevalence of SCC increased with the number of chronic conditions. The association 
between multimorbidity and SCC remained significant after adjustment for a variety of factors. Sleep problems, 
the number of stressful life events and any anxiety disorder explained 14–23% of the relationship. Based on these 
results, we recommend routine screening of SCC and the management of the potential underlying causes of it in 
people with multimorbidity as this may lead to reduced risk for future cognitive decline and also improve patient 
wellbeing or clinical outcomes although more longitudinal and interventional studies are warranted to elucidate 
the utility of assessing SCC in individuals with multimorbidity.
Methods
Study participants. This study used data from 7403 people who participated in the 2007 Adult Psychiatric 
Morbidity Survey (APMS). Full details of the survey have been published elsewhere61. Briefly, this was a nationally 
representative survey of the English adult population (aged ≥16 years) living in private households. The National 
Center for Social Research and Leicester University undertook the survey fieldwork in October 2006 to December 
2007 using a multistage stratified probability sampling design where the sampling frame consisted of the small 
user postcode address file (a listing of all postal delivery points), while the primary sampling units were postcode 
sectors. Participant information was obtained through face-to-face interviews where some of the questionnaire 
items were self-completed (with the use of a computer). The interviewer was instructed to conduct a short proxy 
interview if the selected respondent was not capable of taking part in the survey due to health-related illness, stay 
in hospital, cognitive impairment, or mental incapacity. The data for these proxy interviews were not included in 
the publically available dataset. Sampling weights were constructed to account for non-response and the probabil-
ity of being selected so that the sample was representative of the English adult household population. The survey 
response rate was 57%. Ethical permission for the study was obtained from the Royal Free Hospital and Medical 
School Research Ethics Committee. All participants provided informed consent before their inclusion. All meth-
ods were performed in accordance with the relevant guidelines and regulations.
Measures. Physical multimorbidity. We included data on all 20 physical conditions for which data were 
available in the APMS62. These physical conditions were allergy, arthritis, asthma, bladder problems/incontinence, 
bone/back/joint/muscle problems, bowel/colon problems, bronchitis/emphysema, cancer, cataract/eyesight 
problems, diabetes, ear/hearing problems, epilepsy, heart attack/angina, high blood pressure, infectious disease, 
liver problems, migraine, skin problems, stomach ulcer or other digestive problems, and stroke. These 20 diseases 
are highly prevalent in the general population and are known to have a high burden at the population level. 
Participants self-reported whether they ever had pre-specified doctor diagnosed conditions since the age of 16. 
Specifically, the participant was presented with a card with the names of the health conditions and asked whether 
he or she ever had any of them since the age of 16. For each health condition, the participant was also asked 
whether a doctor or health professional diagnosed the condition, and whether the participant had this health 
condition in the past 12 months. We only included health conditions which were diagnosed by a doctor or a 
health professional, and were present in the past 12 months. The number of physical diseases was summed and 
categorized as 0, 1, 2, 3, and ≥4. Multimorbidity was defined as the presence of two or more physical diseases62.
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Subjective cognitive complaints. SCC included subjective concentration complaints and subjective memory 
complaints. In line with a previous APMS study4, subjective concentration and memory complaints were assessed 
with two questions: “In the past month, have you had any problems with concentrating on what you were doing?” 
(concentration) and “Have you noticed any problems with forgetting things in the past month?” (memory) with 
“yes” and “no” answer options. Two separate dichotomous variables were created for concentration and memory 
based on these answer options.
Influential variables. The influential factors (obesity19,20, smoking21,22, alcohol use23,24, stress and stressful life 
events25–27, depression28,29, anxiety13,30, and sleep problems31,32) were selected based on their previously reported 
associations with SCC and multimorbidity.
Obesity: Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared 
based on self-reported weight and height62. Using the standard WHO definition, obesity was defined as 
BMI ≥ 30 kg/m2, and BMI < 30 kg/m2 was considered no obesity.
Smoking status: Smoking was assessed by the question ‘Have you ever smoked a cigarette?’ with answer 
options “yes” or “no”. Participants were dichotomized as never or current/past smokers62.
Alcohol dependence: Excessive alcohol consumption was screened using the Alcohol Use Disorders 
Identification Test (AUDIT)63. Alcohol dependence was assessed with the Severity of Alcohol Dependence 
Questionnaire (SADQ-C) in participants with an AUDIT score of 10 or above64. Scores of four or above indicated 
alcohol dependence in the past six months.
Stressful life events: Eighteen items were used to assess different stressful life events (e.g., serious illness, death 
of an immediate family member or major financial crises)65. Therefore, the scale ranged from 0 to 18.
Perceived stress: Participants were asked if their tasks at home and at work were stressful66. Answers ranged 
from 0 “not at all” to 3 “most of the time”. Stress was then dichotomized into “not at all” or “occasionally”, “usually” 
and “most of the time”.
Common mental disorders: Common mental disorders were assessed using the Clinical Interview Schedule 
Revised (CIS-R)67,68, and referred to depressive episode and anxiety disorders (generalized anxiety disorder, panic 
disorder, phobia and obsessive-compulsive disorder) in the prior week69.
Sleep problems: Two questions with “yes” and “no” answer options were used to assess sleep problems: “In the 
past month, have you been having problems with trying to get to sleep or with getting back to sleep if you woke 
up or were woken up?” (sleeping less than usual) and “Has sleeping more than you usually do been a problem for 
you in the past month?” (sleeping more than usual). Participants were considered as having sleep problems if they 
reported sleeping less or more than usual70.
control variables. Sociodemographic variables. These included sex, age [16–44 (young adults), 45–64 
(middle-aged adults) and ≥65 years (older adults)], ethnicity (British White: yes or no), qualification (yes or no) 
and income (sex equivalized income tertiles; high ≥£29,826, middle £14,057–<£29,826 and low <£14,057)62. 
Participants were considered qualified if their highest educational qualification was one of the following: degree 
level; teaching, Higher National Diploma (HND) or nursing; A-level; General Certificate of Secondary Education 
(GCSE) or equivalent; and foreign or other qualifications.
Statistical analyses. We deleted the four individuals who self-reported a doctor’s diagnosis of dementia or 
Alzheimer’s disease to focus on a cognitively healthy sample. Differences between groups were tested with chi-squared 
tests for categorical variables and Student’s t-tests for continuous variables (i.e., prevalence of each sample character-
istics among those with and without multimorbidity, and prevalence of SCC among those with and without the 
individual physical diseases). Since previous research has found that multimorbidity patterns may vary with age53, 
tetrachoric correlations between each chronic condition were calculated by age groups. The association between indi-
vidual physical diseases and SCC was estimated by unadjusted logistic regression analysis. The association between 
multimorbidity (explanatory variable) and subjective concentration and memory complaints (outcome variables) was 
assessed by multivariable logistic regression. The model was adjusted for sex, age, ethnicity, qualification and income. 
As more than 20% of the participants had missing income information, a missing category for this variable was 
included in all regression analyses in order to avoid excluding a large number of respondents from the analysis. All 
variables were included in the regression models as categorical variables with the exception of the number of stressful 
life events (continuous variable). All categorical variables were dichotomous variables except age and income, which 
had more than two categories. Age stratified analyses (16–44, 45–64 and ≥65 years) were also conducted as the asso-
ciation between multimorbidity and SCC may differ by age71. In order to assess the influence of multicollinearity, the 
variance inflation factor (VIF) value was calculated for each independent variable. The highest VIF was 1.60, which 
is much lower than the commonly used-cut off of 1072, indicating that multicollinearity was unlikely to be a problem. 
Using the ado-command svylogitgof that allows to account for the complex survey design73, model fit was evaluated 
with the F-adjusted mean residual test, and this test suggested that final models were a good fit for the data.
Finally, mediation analysis was conducted to assess the specific contribution of the different potential influ-
ential factors in the multimorbidity-SCC relationship. We used the khb (Karlson Holm Breen) command in Stata 
for this purpose74. This method can be applied in logistic regression models and decomposes the total effect of a 
variable into direct and indirect effects. Using this method, the percentage of the main association explained by 
the influential factor can also be calculated (mediated percentage). The mediated percentage is the percent atten-
uation in the log odds for the association between multimorbidity and SCC after the influential factor is included 
in the model74. The mediation analysis controlled for sex, age, ethnicity, qualification and income. All influential 
factors were included individually in the model with the exception of the final model where all influential factors 
were included simultaneously.
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We used the Stata svy command that allows for the use of clustered data modified by probability weights. 
Results from the logistic regression analyses are presented as odds ratios (ORs) with 95% confidence intervals 
(CIs). The level of statistical significance was set at p-value < 0.05. All analyses were performed with Stata version 
13.1 (Stata Corp LP, College Station, Texas).
Data Availability
Data can be accessed via the website of the UK Data Archive. However, the present authors cannot directly share 
the data and a request must be sent to the UK Data Archive.
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